Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Real Estate
  • Software
  • Business
  • Education
Washingtoner

Life Insurance Claim Denied for Drunk Driving Pays Out After Investigation
Washingtoner/10260962

Trending...
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
Stephen C. Burgess, President
Denied life insurance claim paid after the Center for Life Insurance Disputes proves blood alcohol of .09 was not Drunk Driving while Tesla's Self-Driving mode was controlling vehicle.

LOS ANGELES - Washingtoner -- The importance of retaining a specialist when you have a life insurance claim investigation.

A California man died in a car crash when his Tesla slammed into a parked fire truck. An investigation showed the Tesla was operating under the full Self-Driving mode when the crash happened. Blood testing results showed the driver had a blood alcohol level of 0.09 (just over the legal limit in California).

The man had life insurance and the family filed a claim for the benefits. To their surprise the life insurance claim was denied because of an exclusion in the policy. The exclusion stated that if the insured dies of injuries that happen while drunk driving the policy will not payout.

More on Washingtoner
  • Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
  • Stamp Me Launches Web App Ahead of 15th Anniversary
  • The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities

The family hired the Center for Life Insurance Disputes to fight the denied life insurance claim.

The Center discovered that Tesla's full Self-Driving function had a significant history of malfunctioning leading to numerous auto accidents – some deadly. The Center also uncovered that two blood test were done post-mortem but because of traffic fatality laws in California only one test result was used by the authorities. However, state regulations for traffic accidents only apply to authorities and don't allow an insurer to obfuscate their fair handling obligations.

The Center took their fight directly to the life insurer and won the appeal.

First, they showed that based on promises by Tesla about the full Self-Driving mode and the large number of accidents that happen while the Self-Driving mode is engaged the insured's alcohol level was immaterial.

More on Washingtoner
  • LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Tacoma: Council Member Sandesh Sadalge Focuses Today's District 4 Town Hall on the City's Biennial Budget
  • City of Tacoma Awarded $2.25 Million in Federal Highway Safety Improvement Program Grant Funding for South 21st Street Corridor
  • New Self-Service Sandbag Station at Tacoma Recovery and Transfer Center

Next, with the assistance of a seasoned toxicologist, they argued that the blood alcohol testing used for the Cause of Death did not sufficiently prove the man was intoxicated at the time of the accident. Rather, the second blood test result showed a blood alcohol level of only 0.07 (below the legal limit) and the insurer was obligated to weigh both results equally.

Without any refusal from the insurer to accept the findings and that the insured was not drunk driving at the time of the accident. The claim was quickly paid and interest was piled on.

Another win by The Center for Life Insurance Disputes.

Contact
Stephen Burgess
***@cflid.com
888-428-4868


Source: The Center for Life Insurance Disputes
Filed Under: Government

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
  • Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
  • Spokane: City Details Veterans Day Schedule
  • The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
  • Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
  • Washington Nurse Introduces Nightingale Care Hub to Help Families Organize Care
  • HIRO Ostomy Belt Launch by Richard O'Hamill
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • Flags Lowered for Spokane County Sheriff Deputies
  • Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
  • ARADIA (Est. 1991) Launches First B2A Partner Program for AI
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
_catLbl0 _catLbl1

Popular on Washingtoner

  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 279
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 245
  • Final Week to Register for Free Spokane Community Conference - 226
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 150
  • LocalsVoted Launches: Local Rankings From Phone-Verified Votes, Not Paid Placement - 146
  • Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 124
  • Sycamore Dove Releases "Loving Every Moment" - 102
  • FloorLine Launches Live Shop Floor Tracking for Small Manufacturers
  • One in three Americans may have lost track of retirement savings from a previous job
  • Datavalet Named One of Quebec's Best Workplaces™ for 2026

Similar on Washingtoner

  • Tacoma: Closures Projected to Allow for Arterial Work
  • Tacoma: Applicants Sought for the Bicycle Pedestrian Technical Advisory Group
  • Spokane City Council Passes Chronic Nuisance Properties Ordinance
  • City of Spokane and City Council Announce 2027 Legislative Priorities
  • Security Planning Tips For Your Holiday Event From Access Patrol Services
  • Tacoma: Council Member Sandesh Sadalge Focuses Today’s District 4 Town Hall on the City’s Biennial Budget
  • City of Tacoma Awarded $2.25 Million in Federal Highway Safety Improvement Program Grant Funding for South 21st Street Corridor
  • New Self-Service Sandbag Station at Tacoma Recovery and Transfer Center
  • Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
  • Kitchen Table Economics: An Invitation to Think Differently
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute